IndraLab
Statements
Thymoquinone inhibits NLRP3. 5 / 5
|
5
reach
"Since the current study showed that TQ significantly inhibited NLRP3 in BC, it would be beneficial to investigate the impact of TQ/cyclin D on CDK4/6 in combination with Abemaciclib in BC, as it might provide a synergistic effect.To date, no clinical trials have investigated the effect of TQ on cancer in general or BC patients in particular."